Literature DB >> 29188724

Dissecting the heterogeneity of stage III non-small-cell lung cancer through incorporation of grade and histology.

Omar Abdel-Rahman1.   

Abstract

AIM: This study evaluated a grade-integrated American Joint Committee on Cancer (AJCC) staging system for non-small-cell lung cancer. PATIENTS &
METHODS: Surveillance, Epidemiology and End Results database was queried through SEER*Stat program. Through recursive partitioning analysis and subsequent decision-tree formation, suggested grade-modified stages were formulated.
RESULTS: All pairwise hazard ratio comparisons among AJCC eighth stages were significant (p < 0.05) except stage IIIB versus stage IIIC; while all pairwise hazard ratio comparisons among modified AJCC stages were significant (p < 0.05). When stratified by histology, there was a benefit for the modified system among adenocarcinoma rather than squamous cell carcinoma patients.
CONCLUSION: Grade integration improved the prognostication of the AJCC staging system particularly for stage III adenocarcinoma. This should be considered in future revisions of the AJCC staging system.

Entities:  

Keywords:  NSCLC; SEER; grade; staging

Mesh:

Year:  2017        PMID: 29188724     DOI: 10.2217/fon-2017-0304

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  1 in total

1.  A Novel Staging System for De Novo Metastatic Breast Cancer Refines Prognostic Estimates.

Authors:  Jennifer K Plichta; Samantha M Thomas; Amanda R Sergesketter; Rachel A Greenup; Laura H Rosenberger; Oluwadamilola M Fayanju; Gretchen Kimmick; Jeremy Force; Terry Hyslop; E Shelley Hwang
Journal:  Ann Surg       Date:  2022-04-01       Impact factor: 13.787

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.